Follow
Jeremy Fournier
Jeremy Fournier
Postdoctoral research associate, University of California, Santa Barbara
Verified email at chem.ucsb.edu
Title
Cited by
Cited by
Year
Palladium-catalyzed asymmetric allylic alkylation of cyclic dienol carbonates: efficient route to enantioenriched γ-butenolides bearing an all-carbon α-quaternary stereogenic …
J Fournier, O Lozano, C Menozzi, S Arseniyadis, J Cossy
Angewandte Chemie 125 (4), 2013
1272013
A Modular and Scalable One‐Pot Synthesis of Polysubstituted Furans
J Fournier, S Arseniyadis, J Cossy
Angewandte Chemie 30 (124), 7680-7684, 2012
772012
A palladium-catalyzed asymmetric allylic alkylation approach to α-quaternary γ-butyrolactones
M Nascimento de Oliveira, J Fournier, S Arseniyadis, J Cossy
Organic letters 19 (1), 14-17, 2017
572017
Discovery of potent and selective non-nucleotide small molecule inhibitors of CD73
JW Beatty, EA Lindsey, R Thomas-Tran, L Debien, D Mandal, JL Jeffrey, ...
Journal of medicinal chemistry 63 (8), 3935-3955, 2020
402020
Total synthesis of unsymmetrically oxidized nuphar thioalkaloids via copper-catalyzed thiolane assembly
JJ Lacharity, J Fournier, P Lu, AK Mailyan, AT Herrmann, A Zakarian
Journal of the American Chemical Society 139 (38), 13272-13275, 2017
372017
Synthesis of functionalized dihydrobenzofurans by direct aryl C− O bond formation under mild conditions
J Alvarado, J Fournier, A Zakarian
Angewandte Chemie 128 (38), 11797-11800, 2016
332016
Discovery of potent and selective PI3Kγ inhibitors
SL Drew, R Thomas-Tran, JW Beatty, J Fournier, KV Lawson, DH Miles, ...
Journal of Medicinal Chemistry 63 (19), 11235-11257, 2020
322020
Palladium-catalyzed allylic alkylation of allyl dienol carbonates: reactivity, regioselectivity, enantioselectivity, and synthetic applications
S Arseniyadis, J Fournier, S Thangavelu, O Lozano, S Prevost, ...
Synlett 24 (18), 2350-2364, 2013
322013
Discovery of potent and selective 7-azaindole isoindolinone-based PI3Kγ inhibitors
DH Miles, X Yan, R Thomas-Tran, J Fournier, EU Sharif, SL Drew, G Mata, ...
ACS Medicinal Chemistry Letters 11 (11), 2244-2252, 2020
152020
Design, synthesis, and structure–activity relationship optimization of pyrazolopyrimidine amide inhibitors of phosphoinositide 3-kinase γ (PI3Kγ)
G Mata, DH Miles, SL Drew, J Fournier, KV Lawson, AK Mailyan, ...
Journal of Medicinal Chemistry 65 (2), 1418-1444, 2021
92021
Development of a Scalable Method for Manufacturing the Central Core of CD73 Inhibitor AB680
J Fournier, X Yan, AT Tran, RL Grange, SD Jacob, J Kalisiak, KV Lawson, ...
Organic Process Research & Development 25 (1), 157-162, 2020
52020
Total Synthesis of Covalent Cysteine Protease Inhibitor N-Desmethyl Thalassospiramide C and Crystallographic Evidence for Its Mode of Action
J Fournier, K Chen, AK Mailyan, JJ Jackson, BO Buckman, K Emayan, ...
Organic letters 21 (2), 508-512, 2019
42019
46P AB521, a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor, for the treatment of renal cell carcinoma
KV Lawson, KES Gauthier, D Piovesan, A Mailyan, G Mata, JTA Fournier, ...
Annals of Oncology 33, S21, 2022
22022
Inhibitors of hif-2alpha
JW Beatty, SL Drew, JTA Fournier, T Guney, SD Jacob, KV Lawson, ...
US Patent App. 17/777,103, 2023
12023
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
JW Beatty, SL Drew, M Epplin, JTA Fournier, GAL Balint, T Guney, ...
US Patent 11,407,712, 2022
12022
Abstract P206: AB521 potently and selectively inhibits pro-tumorigenic gene transcription by Hypoxia-Inducible Factor (HIF)-2α in vitro and in vivo
KES Gauthier, D Piovesan, S Cho, KV Lawson, PG Schweickert, A Lopez, ...
Molecular Cancer Therapeutics 20 (12_Supplement), P206-P206, 2021
12021
Discovery and characterization of AB521, a novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitor
KV Lawson, KES Gauthier, AK Mailyan, JT Fournier, JW Beatty, SL Drew, ...
Cancer Res. 81, 1206, 2021
12021
2, 3, 5-trisubstituted pyrazolo [1, 5-a] pyrimidine compounds
JW BEATTY, SL DREW, JTA FOURNIER, JL JEFFREY, KV LAWSON, ...
12020
Evolution of a Chemical Strategy Toward the Synthesis of Unsymmetrically Oxidized Nuphar Alkaloids
JJ Lacharity, A Zakarian
Synlett 30 (14), 1632-1642, 2019
12019
Inhibitors of hpk1 and methods of use thereof
JR Corbin, S Dhanju, CN Foley, J Fournier, PV Kattamuri, MR Leleti, ...
US Patent App. 18/219,046, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20